Retrospective evaluation of RET biomarker status and outcome to vandetanib in four phase III randomized NSCLC trials.
暂无分享,去创建一个
R. Herbst | P. Elvin | A. Platt | C. Womack | J. S. Lee | Q. Ji | J. Vasselli | R. Boer | Li Zheng | E. Donald | J. Morten | A. Gladwin | Xinying Su